Application of rimazolom in laryngeal mask airway anesthesia during daytime operation: a randomized controlled trial.

Application of rimazolom in laryngeal mask airway anesthesia during daytime operation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037276

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

experimental group:remidazolam

control group:propofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The operation time is less than 2 hours; 2. Aged 18-65 years; 3. BMI 18-29 kg/m2; 4. ASA grade I-II.

Exclusion criteria

Exclusion criteria: 1. The patients who are allergic to remidazolam or propofol; 2. Accompanied by severe allergic history and asthma history; 3. Accompanied by severe heart, lung, liver or renal dysfunction; 4. The patients who have contraindications for laryngeal mask.

Design outcomes

Primary

Measure	Time frame
Hemodynamics;Laryngeal mask insertion condition;Number of remedial cases;BIS;	—

Secondary

Measure	Time frame
induction time;operation time;wake-up time;Vascular active drug usage rate;	—

Countries

China

Contacts

Public ContactKong Gaoyin

Department of Anesthesiology, Hunan Provincial People's Hospital

konggaoyin@sina.com+86 13908476981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026